Lucence makes ultrasensitive non-invasive liquid biopsy tests to provide doctors and their patients life-changing information to enable earlier detection and effective treatment. Headquartered in Palo Alto, Lucence supplies personalized cancer care services through twin CLIA-licensed laboratories in the United States and Singapore.
Location: United States, California, Palo Alto
Employees: 51-200
Phone: +1 888-582-3623
Founded date: 2016
Investors 2
| Date | Name | Website |
| - | Openspace ... | openspacec... |
| - | SGInnovate | sginnovate... |
Mentions in press and media 5
| Date | Title | Description |
| 19.12.2025 | Too much home comfort? Singapore needs more citizens to work abroad and gain international exposure | Listen 19 min New: You can now listen to articles. This audio is generated by an AI tool. Barely two years old, Singapore startup HomePay is already operating across borders and has its sights set on further expansion. Eight staff members o... |
| 10.10.2025 | IHH Healthcare launches Global Incubator to fuel game-changing innovation | By enabling early-stage start-ups to bring breakthrough ideas to life, IHH is catalysing next-level care and driving lasting impact across the healthcare ecosystem. "Through this Global Incubator Programme, we are expanding our innovat... |
| 08.07.2025 | Unexplained weight loss, persistent fatigue – doctors reveal cancer warning signs you shouldn’t ignore | New: You can now listen to articles. This audio is generated by an AI tool. When it comes to the Big C, we know that early detection often leads to a better prognosis. “Cancer remains a leading health concern in Singapore, but early detecti... |
| 02.06.2021 | Lucence : Presents Real-World Evidence on Applications of Liquid Biopsy at 2021 ASCO, Announces Formation of Medical Advisory Board | As part of the 2021 ASCO Annual Meeting, precision oncology company Lucence is sharing real-world data supporting clinical applications of its amplicon-based liquid biopsy assay. The data will be presented in on-demand virtual poster sessio... |
| - | Lucence Partners with Waseda University to Develop an Integrated Liquid Biopsy Platform for Cancer Screening | PALO ALTO, Calif.--(BUSINESS WIRE)--Mar 24, 2021-- Precision oncology company Lucence announced today a partnership with Waseda University in Japan to develop a novel high-speed liquid biopsy laser-based imaging platform for early cancer de... |